Novo Integrated Sciences(NVOS) - 2021 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2021 (State or Other Jurisdiction of Incorporation or Organization) [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004 For the transition period from ___, 20, to __, 20. (Address of Princi ...